Crossmark

Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations

Crossref DOI link: https://doi.org/10.1038/s41379-022-01083-x

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Siegmund, Stephanie E.

Manning, Danielle K.

Davineni, Phani K.

Dong, Fei https://orcid.org/0000-0003-3769-0247
License Information

Text and Data Mining valid from 2022-10-01

Text and Data Mining valid from 2022-10-01

Version of Record valid from 2023-10-07
More Information

This article is maintained by: Elsevier

Article Title: Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations

Journal Title: Modern Pathology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-022-01083-x

Content Type: article

Copyright: © 2022 United States & Canadian Academy of Pathology.

Document is current

Any future updates will be listed below